The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F22%3A00013863" target="_blank" >RIV/75010330:_____/22:00013863 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11110/22:10445464 RIV/00216208:11120/22:43923727 RIV/00064211:_____/22:S0000038

Result on the web

<a href="https://e-coretvasa.cz/artkey/cor-202203-0004_the-power-and-wisdom-of-prevention-cardiovascular-risk-new-challenge-and-approach-to-plwh.php" target="_blank" >https://e-coretvasa.cz/artkey/cor-202203-0004_the-power-and-wisdom-of-prevention-cardiovascular-risk-new-challenge-and-approach-to-plwh.php</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.33678/cor.2021.132" target="_blank" >10.33678/cor.2021.132</a>

Result language

angličtina

Original language name

The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH

Original language description

In recent years, quality of life is one of the important points of discussion among specialists working with people living with HIV (PLWH). With the introduction of highly effective antiretroviral therapy (1996), the expectation of life has dramatically increased and atherosclerotic diseases have become an important cause of morbidity and mortality in people infected with human immunodeficiency virus (HIV). Cardiovascular diseases are the third leading cause of mortality in HIV patients behind non-AIDS-related malignancies and non-AIDS-related infection. One of the many aspects in the treatment of PLWH concerns the prevention of cardiovascular diseases. The absolute risk of developing major cardiovascular disease events (CVD), for example, sudden cardiac death, cardiac arrest, and stroke in HIV-infected patients receiving antiretroviral therapy is still low. However, this risk is increased compared to the risk of uninfected people. This fact is substantially due to a higher prevalence of traditional cardiovascular risk factors that are mostly dependent on the host. Different types of antiretroviral treatment impact differently on metabolic effects and CVD. Prevention of cardiovascular disease in HIV-infected patients is an important goal for a better quality of life. Traditional risk factors should be detected and treated vigorously when possible, to avoid the development of major adverse cardiovascular events (MACE).

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30304 - Public and environmental health

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2022

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Cor et Vasa

ISSN

0010-8650

e-ISSN

1803-7712

Volume of the periodical

64

Issue of the periodical within the volume

3

Country of publishing house

CZ - CZECH REPUBLIC

Number of pages

9

Pages from-to

291-299

UT code for WoS article

000826775300005

EID of the result in the Scopus database

2-s2.0-85135075663